nicardipine has been researched along with Lung Diseases, Obstructive in 2 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the acute effects of nicardipine and a placebo on the response of pulmonary and systemic circulation to different inspiratory fractional concentrations of O2 (FiO2) in 10 patients with pulmonary hypertension secondary to chronic obstructive lung disease." | 9.07 | Effects of nicardipine on pulmonary and systemic vascular reactivity to oxygen in patients with pulmonary hypertension secondary to chronic obstructive lung disease. ( Arnaud, A; Durand, A; Hot, B; Levy, S; Philip-Joët, F; Reynaud-Gaubert, M; Saadjian, A, 1991) |
| "We compared the acute effects of nicardipine and a placebo on the response of pulmonary and systemic circulation to different inspiratory fractional concentrations of O2 (FiO2) in 10 patients with pulmonary hypertension secondary to chronic obstructive lung disease." | 5.07 | Effects of nicardipine on pulmonary and systemic vascular reactivity to oxygen in patients with pulmonary hypertension secondary to chronic obstructive lung disease. ( Arnaud, A; Durand, A; Hot, B; Levy, S; Philip-Joët, F; Reynaud-Gaubert, M; Saadjian, A, 1991) |
| "Nicardipine-based treatment is therefore effective, safe, and well tolerated in elderly hypertensive patients with concomitant disease." | 1.28 | The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases. ( Leonetti, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saadjian, A | 1 |
| Philip-Joët, F | 1 |
| Hot, B | 1 |
| Reynaud-Gaubert, M | 1 |
| Durand, A | 1 |
| Levy, S | 1 |
| Arnaud, A | 1 |
| Leonetti, G | 1 |
1 trial available for nicardipine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effects of nicardipine on pulmonary and systemic vascular reactivity to oxygen in patients with pulmonary hypertension secondary to chronic obstructive lung disease.
Topics: Blood Gas Analysis; Cardiac Output; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Ob | 1991 |
1 other study available for nicardipine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Diabetes Complications; Humans; | 1989 |